0001209191-19-047625.txt : 20190828 0001209191-19-047625.hdr.sgml : 20190828 20190828174814 ACCESSION NUMBER: 0001209191-19-047625 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190826 FILED AS OF DATE: 20190828 DATE AS OF CHANGE: 20190828 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hsu Frank J. CENTRAL INDEX KEY: 0001786723 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50549 FILM NUMBER: 191062986 MAIL ADDRESS: STREET 1: C/O ONCTERNAL THERAPEUTICS, INC. STREET 2: 3525 DEL MAR HEIGHTS ROAD #821 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc. CENTRAL INDEX KEY: 0001260990 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 621715807 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 434-1113 MAIL ADDRESS: STREET 1: 12230 EL CAMINO REAL STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: GTX INC /DE/ DATE OF NAME CHANGE: 20030822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-26 0 0001260990 Oncternal Therapeutics, Inc. ONCT 0001786723 Hsu Frank J. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130 0 1 0 0 Chief Medical Officer Stock Option 5.64 2019-08-26 4 A 0 150000 0.00 D 2029-08-26 Common Stock 150000 150000 D One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. /s/ Hazel M. Aker, Attorney-in-fact 2019-08-28